Renal biopsy in high-risk patients with medical diseases of the kidney

被引：86

作者：

Stiles, KP

Yuan, CM

Chung, EM

Lyon, RD

Lane, JD

Abbott, KC ^{[1
]}

机构：

[1] Walter Reed Army Med Ctr, Serv Nephrol, Dept Med, Washington, DC 20307 USA

[2] Walter Reed Army Med Ctr, Dept Radiol, Intervent Radiol Serv, Washington, DC 20307 USA

[3] Eisenhower Army Med Ctr, Dept Med, Serv Nephrol, Ft Gordon, GA USA

[4] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA

来源：

AMERICAN JOURNAL OF KIDNEY DISEASES | 2000年 / 36卷 / 02期

关键词：

renal biopsy; kidney biopsy; transjugular; transvenous; open; laparoscopic; high risk; coagulopathy; uremia;

D O I：

10.1053/ajkd.2000.8998

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

The number of high-risk patients undergoing renal biopsy is likely to increase in the near future because of the increased use of anticoagulants for such conditions as atrial fibrillation, combined liver and kidney disease caused by hepatitis C, and the aging of the population. Nephrologists need to become increasingly familiar with evaluating such patients through both specialized management of percutaneous kidney biopsy and alternate methods of renal biopsy, which primarily consist of open (surgical) biopsy, transjugular (transvenous) biopsy, and laparoscopic biopsy. The indications, complications, and general approach to such patients are discussed. This is a US government work. There are no restrictions on its use.

引用

页码：419 / 433

页数：15

共 100 条

[1] The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 [J].